Silver Book Fact

Expenditures for glaucoma medications are on the rise–mean annual glaucoma medication expenditures per indiviual increased from $445 in 2001 to $557 in 2006.

Lam, Byron L., D. Diane Zheng, Evelyn P. Davila, Kristopher L. Arheart, Manuel A. Ocasio, Kathryn E. McCollister, Alberto J. Caban-Martinez, and David J. Lee. Trends in Glaucoma Medication Expenditures. Arch Ophthalmol. October 2011; 124(1): 12-9. http://archopht.ama-assn.org/cgi/content/abstract/129/10/1345

Reference

Title
Trends in Glaucoma Medication Expenditures
Publication
Arch Ophthalmol
Publication Date
October 2011
Authors
Lam, Byron L., D. Diane Zheng, Evelyn P. Davila, Kristopher L. Arheart, Manuel A. Ocasio, Kathryn E. McCollister, Alberto J. Caban-Martinez, and David J. Lee
Volume & Issue
Volume 124, Issue 1
Pages
12-9
URL
Read Full Resource

Categories

  • Cost of Disease
  • Economic Burden

Related Facts

  • People Affected Worldwide by DR
    By 2030, more than 191 million people around the world will be affected by DR—56 million with vision-threatening DR.  
  • Around 648,000 Americans age 80 and older are blind– 7% of the 80 and older population.  
  • Individuals who are visually impaired are less likely to be employed–44% are employed compared to 85% of adults with normal vision.  
  • More than 2.1 million Americans age 80 and older have low vision or are blind– 23.7% of the 80 and older population.  
  • Age-related macular degeneration (AMD) is the leading cause of blindness among white Americans– accounting for 54% of cases of blindness.